T

he trade group for generic drug makers has filed a lawsuit charging that a new Maryland law designed to punish companies for price gouging is unconstitutional.

In making its case, the Association for Accessible Medicines argued the law violates interstate commerce by giving Maryland officials the right to govern business outside the state, effectively providing “unprecedented powers to regulate the national pharmaceutical market.” The trade group also maintained the law too vaguely defines “excessive” pricing, which would violate due process.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of news in health and medicine.

X